Skip to main content

Reverse Phase Protein Arrays and Drug Discovery

  • Protocol
  • First Online:
Proteomics for Drug Discovery

Part of the book series: Methods in Molecular Biology ((MIMB,volume 1647))

Abstract

Reverse Phase Protein Arrays (RPPA) represent a sensitive antibody-based proteomic approach, which enables simultaneous quantification of the abundance of multiple proteins and posttranslational modifications across multiple samples. Here, we provide protocols for RPPA performed on two distinct protein-binding substrates associated with two most commonly used RPPA platform technologies. We compare and contrast the respective advantages and limitations of each platform within the context of drug discovery applications.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

Similar content being viewed by others

References

  1. Paweletz CP, Charboneau L, Bichsel VE et al (2001) Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front. Oncogene 20(16):1981–1989

    Article  CAS  PubMed  Google Scholar 

  2. Pawlak M, Schick E, Bopp MA, Schneider MJ, Oroszlan P, Ehrat M (2002) Zeptosens' protein microarrays: a novel high performance microarray platform for low abundance protein analysis. Proteomics 2(4):383–393

    Article  CAS  PubMed  Google Scholar 

  3. Weissenstein U, Schneider MJ, Pawlak M et al (2006) Protein chip based miniaturized assay for the simultaneous quantitative monitoring of cancer biomarkers in tissue extracts. Proteomics 6(5):1427–1436

    Article  CAS  PubMed  Google Scholar 

  4. Boyd ZS, Wu QJ, O'brien C et al (2008) Proteomic analysis of breast cancer molecular subtypes and biomarkers of response to targeted kinase inhibitors using reverse-phase protein microarrays. Mol Cancer Ther 7(12):3695–3706

    Article  CAS  PubMed  Google Scholar 

  5. Voshol H, Ehrat M, Traenkle J, Bertrand E, Van Oostrum J (2009) Antibody-based proteomics: analysis of signaling networks using reverse protein arrays. FEBS J 276(23):6871–6879

    Article  CAS  PubMed  Google Scholar 

  6. Cardnell RJ, Feng Y, Diao L et al (2013) Proteomic markers of DNA repair and PI3K pathway activation predict response to the PARP inhibitor BMN 673 in small cell lung cancer. Clin Cancer Res 19(22):6322–6328

    Article  CAS  PubMed  Google Scholar 

  7. Girotti MR, Lopes F, Preece N et al (2015) Paradox-breaking RAF inhibitors that also target SRC are effective in drug-resistant BRAF mutant melanoma. Cancer Cell 27(1):85–96

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Akbani R, Becker KF, Carragher N et al (2014) Realizing the promise of reverse phase protein arrays for clinical, translational, and basic research: a workshop report: the RPPA (reverse phase protein array) society. Mol Cell Proteomics 13(7):1625–1643

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Cancer Genome Atlas Network (2012) Comprehensive molecular portraits of human breast tumours. Nature 490(7418):61–70

    Article  Google Scholar 

  10. Mircean C, Shmulevich I, Cogdell D et al (2005) Robust estimation of protein expression ratios with lysate microarray technology. Bioinformatics 21(9):1935–1942

    Article  CAS  PubMed  Google Scholar 

  11. Nishizuka S, Charboneau L, Young L et al (2003) Proteomic profiling of the NCI-60 cancer cell lines using new high-density reverse-phase lysate microarrays. Proc Natl Acad Sci U S A 100(24):14229–14234

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Hu J, He X, Baggerly KA, Coombes KR, Hennessy BT, Mills GB (2007) Non-parametric quantification of protein lysate arrays. Bioinformatics 23(15):1986–1994

    Article  CAS  PubMed  Google Scholar 

  13. Troncale S, Barbet A, Coulibaly L et al (2012) NormaCurve: a SuperCurve-based method that simultaneously quantifies and normalizes reverse phase protein array data. PLoS One 7(6):e38686

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Sun M, Lai D, Zhang L, Huang X (2015) Modified SuperCurve method for analysis of reverse-phase protein Array data. J Comput Biol 22(8):765–769

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Neil O. Carragher .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer Science+Business Media LLC

About this protocol

Cite this protocol

Macleod, K.G., Serrels, B., Carragher, N.O. (2017). Reverse Phase Protein Arrays and Drug Discovery. In: Lazar, I., Kontoyianni, M., Lazar, A. (eds) Proteomics for Drug Discovery. Methods in Molecular Biology, vol 1647. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-7201-2_10

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-7201-2_10

  • Published:

  • Publisher Name: Humana Press, New York, NY

  • Print ISBN: 978-1-4939-7200-5

  • Online ISBN: 978-1-4939-7201-2

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics